4//SEC Filing
Burkly Linda 4
Accession 0001650664-25-000143
CIK 0001650664other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 4:21 PM ET
Size
5.2 KB
Accession
0001650664-25-000143
Insider Transaction Report
Form 4
Burkly Linda
EVP, CHIEF SCIENTIFIC OFFICER
Transactions
- Sale
Common Stock
2025-09-03$2.60/sh−710$1,843→ 69,490 total
Footnotes (2)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2025. The sale does not represent a discretionary trade by the Reporting Person.
- [F2]The amount of securities beneficially owned following the reported transaction includes 5,802 shares acquired under the Issuer's Employee Stock Purchase Plan.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001985604
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 4:21 PM ET
- Size
- 5.2 KB